8-mop

   
Google
 
Web NewDrugInformation.com

8-mop


Drug - 8-mop
The trade name of the product as shown on the labeling.

Dosage - CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Methoxsalen
Multiple ingredients are in alphabetical order.

Strength - 10MG
The potency of the active ingredient(s), Methoxsalen. May repeat for multiple part products.

Applicant - VALEANT PHARM INTL
The firm name holding legal responsibility for 8-mop. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 009048
The FDA assigned number to 8-mop. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify 8-mop. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date 8-mop was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of 8-mop. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs 8-mop is in. Format is RX, OTC, DISCN.

Applicant Full Name - Valeant Pharmaceuticals International
The full name of the firm holding legal responsibility for the new application of 8-mop.

8-mop